Industry
Walgreen explores sale of $1.5 billion infusion business: sources
U.S. drugstore chain operator Walgreen Co (WAG.N) is exploring the sale of a majority stake in its infusion services business, in a deal that could value that division at around $1.5 billion, according to four people familiar with the matter.
Wall St. ends lower, S&P 500 falls for third straight da
U.S. stocks fell on Tuesday, with consumer staples leading the S&P 500 down to its third straight daily loss, as investors grew concerned about the pace of global economic growth.
AstraZeneca, Shire fall as U.S. tax move punctures deal hopes
Shares in drugmakers AstraZeneca (AZN.L) and Shire (SHP.L) both fell more than 5 percent on Tuesday after the U.S. Treasury took steps to curb "inversion" deals that allow companies to escape high U.S. taxes by reincorporating abroad.
Euro zone business growth slows in September as prices keep sliding: PMI
Euro zone business activity has expanded at a slightly weaker pace than expected in September as firms cut prices for the 30th month in a row, a survey showed on Tuesday.